Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer

被引：0
|
作者：
Sung Gwe Ahn
Yoon Jin Cha
Soon June Bae
Chanik Yoon
Hak Woo Lee
Joon Jeong
机构：
[1] Yonsei University College of Medicine,Department of Surgery, Gangnam Severance Hospital
[2] Yonsei University College of Medicine,Department of Pathology, Gangnam Severance Hospital
来源：
BMC Cancer | / 18卷
关键词：
Tumor-infiltrating lymphocytes; 21-gene recurrence score; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
    Mamounas, Eleftherios P.
    Liu, Qing
    Paik, Soonmyung
    Baehner, Frederick L.
    Tang, Gong
    Jeong, Jong-Hyeon
    Kim, S. Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Sing, Amy P.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (04):
  • [32] 21-gene recurrence score® in patients with primary metastatic ER+HER2-breast cancer
    Barinoff, J.
    Anastasiadou, L.
    Brandi, C.
    Junker-Stein, A.
    Silbermann, J.
    Langenfeld, M.
    Fortmann, C.
    Thill, M.
    CANCER RESEARCH, 2017, 77
  • [33] The EndoPredict Score Is a Response Predictor for Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer.
    Brase, J. C.
    Gehrmann, M. C.
    Petry, C.
    Weber, K. E.
    Schmidt, M.
    Koelbl, H.
    Brauch, H.
    Schwab, M.
    Mueller, V.
    Jaenicke, F.
    Rody, A.
    Kaufmann, M.
    Filipits, M.
    Gnant, M.
    Denkert, C.
    Loibl, S.
    von Minckwitz, G.
    Kronenwett, R.
    CANCER RESEARCH, 2011, 71
  • [34] META-ANALYSIS OF PROSPECTIVE EUROPEAN STUDIES ASSESSING THE IMPACT OF USING THE 21-GENE RECURRENCE SCORE ASSAY ON CLINICAL DECISION MAKING IN WOMEN WITH ER-POSITIVE, HER2-NEGATIVE EARLY STAGE BREAST CANCER
    Albanell, J.
    Holt, S.
    Gligorov, J.
    Eiermann, W.
    Svedman, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 97 - 97
  • [35] The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
    Weiser, Roi
    Haque, Waqar
    Polychronopoulou, Efstathia
    Hatch, Sandra S.
    Kuo, Yong-fang
    Gradishar, William J.
    Klimberg, V. Suzanne
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (03) : 667 - 676
  • [36] The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
    Roi Weiser
    Waqar Haque
    Efstathia Polychronopoulou
    Sandra S. Hatch
    Yong-fang Kuo
    William J. Gradishar
    V. Suzanne Klimberg
    Breast Cancer Research and Treatment, 2021, 185 : 667 - 676
  • [37] Novel Endocrine Therapy Agents in ER-Positive, HER2-Negative Breast Cancer
    Hamilton, Erika P.
    Rugo, Hope S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (03) : 125 - 127
  • [38] Discordant classification and outcomes between Prosigna and Oncotype Dx Recurrence Score for ER-positive, HER2-negative, node-negative breast cancer
    Sestak, Ivana
    Ferree, Sean
    Shemesh, Itay
    Buckingham, Wesley
    Cuzick, Jack
    Dowsett, Mitchell
    CANCER RESEARCH, 2020, 80 (04)
  • [39] The impact of intratumoral heterogeneity on the prognosis of ER-positive/HER2-negative breast cancer
    Oikawa, Masahiro
    Ishida, Mayumi
    Nakamura, Yoshiaki
    Nishimura, Sumiko
    Koga, Chinami
    Saruwatari, Akihiro
    Igawa, Akiko
    Akiyoshi, Sayuri
    Koi, Yumiko
    Ohno, Shinji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer
    Hoste, G.
    Punie, K.
    Wildiers, H.
    Beuselinck, B.
    Lefever, I.
    Van Nieuwenhuysen, E.
    Han, S. N.
    Berteloot, P.
    Concin, N.
    Salihi, R.
    Vergote, I.
    Neven, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 131 - 141
12345